Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/40752| metadata.artigo.dc.title: | Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes |
| metadata.artigo.dc.creator: | Iacobellis, Gianluca Penaherrera, Carlos A. Bermudez, Luis E. Bernal Mizrachi, Ernesto |
| metadata.artigo.dc.subject: | COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hyperglycemia Diabetes |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | 2020 |
| metadata.artigo.dc.identifier.citation: | IACOBELLIS, G. et al. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes. Diabetes Research and Clinical Practice, [S.l.], v. 164, 2020. |
| metadata.artigo.dc.description.abstract: | Diabetes emerged as major risk factor for severe acute respiratory syndrome (SARS) and adverse outcome in patients with the coronavirus disease 2019 (COVID-19). Nevertheless, the role of admission hyperglycemia in patients with COVID-19 has not been well-explored, yet. With this retrospective analysis, we report for the first time that hyperglycemia on day-1 is the best predictor of radiographic imaging of SARS-CoV2, regardless of the past medical history of diabetes. Admission hyperglycemia should not be overlooked, but adequately treated to improve the outcomes of COVID-19 patients with our without diabetes. |
| metadata.artigo.dc.identifier.uri: | http://www.sciencedirect.com/science/article/pii/S0168822720304356 http://repositorio.ufla.br/jspui/handle/1/40752 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.